http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Boston Scientific (BSX) Says it Prevailed in German Edwards Lifesciences (EW) Litigation
-
Edwards Lifesciences To Host Earnings Conference Call On October 23, 2018
-
Edwards Lifesciences (EW) Reports Commencement of U.S. Study of Self-Expanding Transcatheter Heart Valve
-
Edwards Announces Start Of U.S. Study Of Self-Expanding Transcatheter Heart Valve
-
Edwards Lifesciences' Philanthropy Exceeds Every Heartbeat Matters Goal To Impact One Million Underserved People Ahead Of Schedule
-
Edwards Lifesciences To Present At The 13th Annual Wells Fargo Healthcare Conference
-
Edwards Lifesciences To Present at 38th Annual Canaccord Genuity Growth Conference
-
Pre-Open Movers 07/27: (TTPH) (TEAM) (EXPE) Higher; (IMPV) (SAM) (TWTR) Lower (more...)
-
Edwards Lifesciences Reports Second Quarter Results
-
Edwards Lifesciences To Host Earnings Conference Call on July 26, 2018
-
Edwards Lifesciences To Present At The Bernstein 34th Annual Strategic Decisions Conference
-
Edwards Lifesciences (EW) Says Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With its SAPIEN 3 Valve
-
Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve
-
Edwards Announces Key Events For EuroPCR 2018
-
Edwards Lifesciences To Webcast Annual Meeting Of Stockholders
-
Edwards Lifesciences (EW) Enters $400M Accelerated Share Repurchase Plan
-
Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement
-
Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy
-
Pre-Open Movers 04/25: (VICR) (TZOO) (CREE) Higher; (TRVG) (TER) (EW) Lower (more...)
-
Edwards Lifesciences Reports First Quarter Results
-
Boston Scientific (BSX) Prevails In European Patent Dispute With Edwards Lifesciences (EW)
-
Edwards Lifesciences To Host Earnings Conference Call On April 24, 2018
-
Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid
-
Edwards (EW) Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe
-
Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe
-
Edwards' Acumen Hypotension Prediction Index Launches In The U.S.
-
Edwards Lifesciences To Present At The Cowen 38th Annual Health Care Conference
-
Edwards Lifesciences (EW) Announces Self-Expanding Transcatheter Heart Valve Received CE Mark
-
Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark
-
Edwards Lifesciences Reports Fourth Quarter Results
-
Edwards Lifesciences To Host Earnings Conference Call On February 1, 2018
-
Edwards Lifesciences To Present At The 36th Annual J.P. Morgan Healthcare Conference
-
Edwards Lifesciences (EW) Announces New $1B Stock Buyback, Enters $150M Accelerated Repurchase
-
Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program
-
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
-
Edwards Lifesciences (EW) to Acquire Harpoon Medical for $100M, Plus Up to $150M in Milestone Payments
-
Edwards Acquires Harpoon Medical
-
Edwards SAPIEN 3 Transcatheter Valve Demonstrates Significant Cost Savings Over Surgery In Intermediate Risk Patients
-
Edwards Lifesciences Reports Third Quarter Results
-
Edwards Lifesciences To Host Earnings Conference Call On October 24, 2017
-
Edwards Announces Key Events For PCR London Valves 2017
-
Edwards Lifesciences To Present At The 12th Annual Wells Fargo Healthcare Conference
-
Edwards Lifesciences To Present At 37th Annual Canaccord Genuity Growth Conference
-
Pre-Open Stock Movers 07/27: (CAPR) (SHOR) (FB) Higher; (CUR) (AZN) (CYH) Lower (more...)
-
Edwards Lifesciences Reports Second Quarter Results
-
Edwards Lifesciences To Host Earnings Conference Call On July 26, 2017
-
Edwards Lifesciences (EW) Granted FDA Approval for INSPIRIS RESILIA Aortic Valve
-
Edwards' INSPIRIS RESILIA Valve Receives FDA Approval
-
Edwards Lifesciences To Present At Goldman Sachs 38th Annual Global Healthcare Conference
-
Edwards Lifesciences (EW) Announces SAPIEN 3 Valve Receives FDA Approval For Aortic, Mitral Valve-In-Valve Procedures

